Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co LtdfiledCriticalKaken Pharmaceutical Co Ltd
Priority to JP7827785ApriorityCriticalpatent/JPS61236773A/ja
Publication of JPS61236773ApublicationCriticalpatent/JPS61236773A/ja
Publication of JPH0558434B2publicationCriticalpatent/JPH0558434B2/ja
Composto de n-fenilarilsulfonamida, fármaco contendo o composto como ingrediente activo, produtos intermédios para a produção do composto e processos para a produção do composto
Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
N-oe6-methoxy-5-(perflouralkyl)-1-naphthoylaa-n-methylglyciner og deres thionaphthoylanaloge, deres fremstilling og farmaceutiske praeparater indeholdende dem
Novel 1-benzhydryl-4-cinnamylpiperazine derivatives, and pharmaceutical compositions comprising said compounds as active ingredient for treating a cerebrovascular disease